Updates on Current Treatment Options for RA-ILD
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
CME/CE Information is available within the activity.
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA